Royalty Pharma partners with J&J on $500M drug development deal
Go back to Royalty Pharma partners with J&J on $500M drug development deal| Johnson & Johnson (NYSE: JNJ) | Delayed: 269.17 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $269.17 | 52 Week High | $126.07 | |||
| Open | $269.17 | 52 Week Low | $94.28 | |||
| Day High | $269.17 | P/E | 55.96 | |||
| Day Low | $269.17 | EPS | $4.81 | |||
| Volume | 3,525 | |||||
| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 57.65 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.65 | 52 Week High | $3.48 | |||
| Open | $57.65 | 52 Week Low | $0.80 | |||
| Day High | $57.65 | P/E | N/A | |||
| Day Low | $57.65 | EPS | $-1.54 | |||
| Volume | 121 | |||||
